Skip to main content
. 2021 Jun 15;6(4):100171. doi: 10.1016/j.esmoop.2021.100171

Table 2.

Overall response and response related to radiopharmaceuticals

Response Overall
90Y-DOTATOC
177Lu-DOTATATE
n (%) n (%) n (%)
PR 4 (8.7) 1 (8.3) 3 (8.9)
SD 33 (71.7) 8 (66.7) 25 (73.5)
DCR (PR + SD) 37 (80.4) 9 (75.0) 28 (82.4)
PD 9 (19.6) 3 (25.0) 6 (17.6)

DCR, disease control rate; PD, progressive disease; PR, partial response; SD, stable disease.